MoHFW prohibited the manufacture, sale, and distribution of the drug fixed dose combination of Chlorpheniramine + Codeine Phosphate + Menthol Syrup

Jun 03, 2023 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe Ministry of Health and Family Welfare (MoHFW) on June 02, 2023, issued a notification regarding the prohibition of the manufacture, sale, or distribution of drugs for human use the fixed-dose combination of Chlorpheniramine + Codeine Phosphate + Menthol Syrup.

This shall come into force on June 02, 2023.

The following has been stated namely: -

•This is in supersession of the notification of the Government of India, Ministry of Health and Family Welfare Notification number S.O. 983(E), dated March 10, 2016.

•It has been decided to prohibit the manufacture for sale, sale, or distribution for human use of drug fixed dose combination Chlorpheniramine + Codeine Phosphate + Menthol Syrup with immediate effect.

[Notification No. S.O. 2404(E)]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT